CC Small or few human trials. Promising, not proven. How we grade →Retrospective cohort and twin study · Danish national registers, singletons and discordant twin pairs
Reassessing the evidence of a survival advantage in Type 2 diabetes treated with metformin compared with controls without diabetes: a retrospective cohort study
M Keys, M Thinggaard, L Larsen, D Pedersen, J Hallas, K Christensen. International Journal of Epidemiology. 2022.
- In plain language
- In Danish registers, people with type 2 diabetes starting metformin had higher mortality than people without diabetes (adjusted rate ratio 1.32; 1.64 in twin pairs), so the earlier survival advantage was not reproduced.
- Limits
- Observational; one country.
- Which of our grades it feeds
- DD Mostly mechanistic or early data. Shown openly. How we grade →Science summary: Metformin as an aging drug: what the evidence shows, and why the TAME trial has not started
- Source
- doi.org/10.1093/ije/dyac200 · PubMed 36287641
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.